L'ospedale Infermi è l'ospedale pubblico della città di Rimini, situato a sud della città, ma non lontano dal centro cittadino.

During the past decade, Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia conducted 17 clinical trials. In the 10-year time frame, 17 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" #1 collaborator was "ERIC Group" with 1 trials as a collaborator, "GRADE Onlus" with 1 trials as a collaborator and "Janssen-Cilag S.p.A." with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" are "Acute Myeloid Leukemia" (2 trials), "Chronic Myeloid Leukemia" (2 trials), "Acute Lymphoid Leukemia" (1 trials), "Adults" (1 trials) and "Chronic Lymphocytic Leukemia" (1 trials). Many other conditions were trialed in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" in a lesser frequency.

Most popular intervention types in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" are "Drug" (13 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Rituximab" (2 trials), "Chemotherapy" (1 trials), "Consolidation with ADCT-402 (loncastuximab tesirine) after salvage immunochemotherapy (R-BAC, Rituximab - Bendamustine, Ara-C))" (1 trials), "Gemtuzumab Ozogamicin" (1 trials) and "Glasdegib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia" are 18 trials for "All" genders.

Currently, there are NaN active trials in "Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia". 2 are not yet recruiting, 9 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ausl Della Romagna, Ospedale "Infermi" - Rimini - Uo Ematologia, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".